146 related articles for article (PubMed ID: 25677163)
21. CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.
Olteanu H; Harrington AM; Kroft SH
Am J Clin Pathol; 2012 Dec; 138(6):867-76. PubMed ID: 23161721
[TBL] [Abstract][Full Text] [Related]
22. Paraproteins: a regional South Australian experience.
Roberts-Thomson PJ; Nikoloutsopoulos T; Smith AJ
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):187-95. PubMed ID: 12587843
[TBL] [Abstract][Full Text] [Related]
23. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.
Ocio EM; del Carpio D; Caballero Á; Alonso J; Paiva B; Pesoa R; Villaescusa T; López-Anglada L; Vidriales B; García-Sanz R
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):93-5. PubMed ID: 21454201
[TBL] [Abstract][Full Text] [Related]
25. T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia.
San Miguel JF; Caballero MD; Gonzalez M
Am J Hematol; 1985 Nov; 20(3):267-73. PubMed ID: 3933332
[TBL] [Abstract][Full Text] [Related]
26. Familial paraproteinemia: hyper-responsive B-cells as endophenotype.
Ögmundsdóttir HM; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):82-4. PubMed ID: 21454198
[TBL] [Abstract][Full Text] [Related]
27. Autosomal-dominant inheritance of hyperphosphorylated paratarg-7.
Grass S; Preuss KD; Pfreundschuh M
Lancet Oncol; 2010 Jan; 11(1):12. PubMed ID: 20129126
[No Abstract] [Full Text] [Related]
28. [Epidemiology of monoclonal gammopathies].
Hurez D
Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953
[TBL] [Abstract][Full Text] [Related]
29. Detection of anti-histone activity in sera of patients with monoclonal gammopathies.
Shoenfeld Y; el-Roeiy A; Ben-Yehuda O; Pick AI
Clin Immunol Immunopathol; 1987 Feb; 42(2):250-8. PubMed ID: 3100119
[TBL] [Abstract][Full Text] [Related]
30. [The clinical significance of M proteins].
Sasaki R
Rinsho Byori; 2001 Jul; 49(7):678-81. PubMed ID: 11519130
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
[TBL] [Abstract][Full Text] [Related]
32. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
34. Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders.
Auwerda JJ; Sonneveld P; de Maat MP; Leebeek FW
Clin Lymphoma Myeloma; 2007 Jul; 7(7):462-6. PubMed ID: 17875234
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
36. Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A.
Preuss KD; Pfreundschuh M; Fadle N; Regitz E; Raudies S; Murwaski N; Ahlgrimm M; Bittenbring J; Klotz M; Schäfer KH; Held G; Neumann F; Grass S
Blood; 2011 Sep; 118(12):3340-6. PubMed ID: 21791414
[TBL] [Abstract][Full Text] [Related]
37. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?
Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM
Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851
[TBL] [Abstract][Full Text] [Related]
38. [Monoclonal gammopathies of undetermined significance called "MGUS"].
Clément F
Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
[TBL] [Abstract][Full Text] [Related]
39. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
[TBL] [Abstract][Full Text] [Related]
40. Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
Goodyear OC; Pratt G; McLarnon A; Cook M; Piper K; Moss P
Blood; 2008 Oct; 112(8):3362-72. PubMed ID: 18658027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
